Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Aubrey R, Turner"'
Autor:
Bao-Li Chang, Jianfeng Xu, Henrik Grönberg, William Isaacs, John Carpten, David Duggan, Jin Woo Kim, Wennuan Liu, Pär Stattin, Aubrey R. Turner, Fang-Chi Hsu, Zheng Zhang, Yi Zhu, Seong-Tae Kim, Kathleen E. Wiley, Ge Li, Sarah D. Isaacs, Fredrik Wiklund, Siqun Lilly Zheng, Jielin Sun
Supplementary Methods, Tables and Figures from Sequence Variants at 22q13 Are Associated with Prostate Cancer Risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5503dca7c4264a0fbc4004d86cf7d259
https://doi.org/10.1158/0008-5472.22376708.v1
https://doi.org/10.1158/0008-5472.22376708.v1
Autor:
Wennuan Liu, Chunmei Carol Xie, Yi Zhu, Tao Li, Jishan Sun, Yu Cheng, Charles M. Ewing, Sue Dalrymple, Aubrey R. Turner, Jielin Sun, John T. Isascs, Bao-Li Chang, Siqun Lilly Zheng, William B. Isaacs, Jianfeng Xu
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 10, Iss 8, Pp 897-907 (2008)
Prostate cancer cell lines provide ideal in vitro systems for the identification and analysis of prostate tumor suppressors and oncogenes. A detailed characterization of the architecture of prostate cancer cell line genomes would facilitate the study
Externí odkaz:
https://doaj.org/article/51026de792f347338ae71ec0638f853f
Autor:
Jin W Kim, Seong-Tae Kim, Aubrey R Turner, Tracey Young, Shelly Smith, Wennuan Liu, Johan Lindberg, Lars Egevad, Henrik Gronberg, William B Isaacs, Jianfeng Xu
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48455 (2012)
Many differentially methylated genes have been identified in prostate cancer (PCa), primarily using candidate gene-based assays. Recently, several global DNA methylation profiles have been reported in PCa, however, each of these has weaknesses in ter
Externí odkaz:
https://doaj.org/article/d1e859eefe984d9b9ed97a60f25dadcb
Autor:
Trudy McKanna, Kathryn E. Weaver, Fang-Chi Hsu, Thomas Monroe, Sabrina L. Noyes, S. Lilly Zheng, Zheng Zhang, Ryan Rodarmer, A. Karim Kader, Mouafak Tourojman, Tracey Young, Brian R. Lane, William H. Baer, Aubrey R. Turner, Isaac M. Lipkus, Helga V. Toriello, Dan Rogers, Richard J. Kahnoski, Tamara S. Adams, Suzanne C. Danhauer, Jianfeng Xu
Publikováno v:
Cancer. 122:3564-3575
BACKGROUND Prostate-specific antigen (PSA) screening may reduce death due to prostate cancer but leads to the overdiagnosis of many cases of indolent cancer. Targeted use of PSA screening may reduce overdiagnosis. Multimarker genomic testing shows pr
Autor:
Zheng Zhang, John C. Whittaker, Roger S. Rittmaster, John D. McConnell, Brian R. Lane, Sha Tao, Deborah A. Meyers, Lynn D. Condreay, Frank M. Torti, Jianfeng Xu, William B. Isaacs, Aubrey R. Turner, Ralph B. D'Agostino, Greg T. Platek, Jielin Sun, Fang-Chi Hsu, Seong Tae Kim, Jeffery M. Trent, A. Karim Kader, S. Lilly Zheng, Paul J. Newcombe, Brian H. Reck, Colin F. Spraggs, Eugene R. Bleecker
Publikováno v:
European Urology. 62:953-961
Several germline single nucleotide polymorphisms (SNPs) have been consistently associated with prostate cancer (PCa) risk.To determine whether there is an improvement in PCa risk prediction by adding these SNPs to existing predictors of PCa.Subjects
Autor:
Charles M. Ewing, Seong Tae Kim, Junjie Feng, Y. Yan, Jishan Sun, Zheng Zhang, Zhong Wang, Guangchao Sui, Lars Egevad, Siqun Zheng, Meimei Wan, Jun Luo, Jianfeng Xu, Robert L. Vessella, Scott D. Cramer, Tao Li, Guifang Yan, Chunmei C. Xie, Marta Gielzak, G. S. Bova, Wennuan Liu, Aubrey R. Turner, W. Isaacs, Henrik Grönberg, Johan Lindberg
Publikováno v:
Oncogene. 31:3939-3948
A clearer definition of the molecular determinants that drive the development and progression of prostate cancer (PCa) is urgently needed. Efforts to map recurrent somatic deletions in the tumor genome, especially homozygous deletions (HODs), have pr
Autor:
Fang-Chi Hsu, Seong Tae Kim, A. Karim Kader, Aubrey R. Turner, William B. Isaacs, Fredrik Wiklund, Jan Adolfsson, Jielin Sun, Zheng Zhang, Jianfeng Xu, Yi Zhu, S. Lilly Zheng, Henrik Grönberg, Tao Jin
Publikováno v:
The Prostate. 71:421-430
BACKGROUND Prostate cancer (PCa) risk-associated single-nucleotide polymorphisms (SNPs) are continuously being discovered. Their ability to identify men at high risk and the impact of increasing numbers of SNPs on predictive performance are not well
Autor:
Lina Purcell, Jielin Sun, Jan-Erik Johansson, John D. Carpten, David Duggan, Yi Zhu, Zhengrong Gao, Henrik Grönberg, Jan Adolfsson, Hans-Olov Adami, Fang-Chi Hsu, S. Lilly Zheng, Pär Stattin, Fredrik Wiklund, Wennuan Liu, Aubrey R. Turner, Bao Li Chang, Tamara S. Adams, Jianfeng Xu, William B. Isaacs
Publikováno v:
Clinical Cancer Research. 15:1105-1111
Purpose: Although prostate-specific antigen (PSA) is the best biomarker for predicting prostate cancer, its predictive performance needs to be improved. Results from the Prostate Cancer Prevention Trial revealed the overall performance measured by th
Autor:
Lina Romero, Henrik Grönberg, Jan Adolfsson, Sarah D. Isaacs, Kristen Pruett, Bao Li Chang, Shelly G. Smith, Fredrik Wiklund, John D. Carpten, Jianfeng Xu, Victoria L. Stevens, Carmen Rodriguez, Fang-Chi Hsu, Seong Tae Kim, David Duggan, William B. Isaacs, Yi Zhu, Kathleen E. Wiley, S. Lilly Zheng, Zheng Zhang, Jielin Sun, Aubrey R. Turner, Jin Woo Kim, Scott D. Cramer, Wennuan Liu
Publikováno v:
Karolinska Institutet
A single nucleotide polymorphism (SNP) at 10q11 (rs10993994) in the 5' region of the MSMB gene was recently implicated in prostate cancer risk in two genome-wide association studies. To identify possible causal variants in the region, we genotyped 16
Autor:
Jielin Sun, Yi Zhu, Henrik Grönberg, Kathleen E. Wiley, Baoli Chang, Ge Li, William B. Isaacs, Alan W. Partin, Bruce J. Trock, Siqun Zheng, Patrick C. Walsh, Tamara S. Adams, Jianfeng Xu, Fredrik Wiklund, Wennuan Liu, Aubrey R. Turner, Sarah D. Isaacs, Fang-Chi Hsu
Publikováno v:
Clinical Cancer Research. 14:5819-5824
Purpose: Fifteen independent genetic variants have been implicated in prostate cancer risk by recent genome-wide association studies. However, their association with clinicopathologic features of prostate cancer is uncertain. Experimental Design: We